n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with thiazoles in 4 studies
| Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (thiazoles) | Trials (thiazoles) | Recent Studies (post-2010) (thiazoles) |
|---|---|---|---|---|---|
| 214 | 5 | 58 | 33,179 | 2,100 | 12,330 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dušek, L; Hofer, M; Hoferová, Z; Pospíšil, M; Weiterová, L | 1 |
| Dušek, L; Hofer, M; Hoferová, Z; Komůrková, D; Pospíšil, M | 1 |
| Castonguay, A; Chen, Z; Cottet, M; De Koninck, Y; Doyle, T; Egan, TM; Ford, A; Jacobson, KA; Little, JW; Salvemini, D; Symons-Liguori, AM; Tosh, DK; Vanderah, TW | 1 |
| Warren, RB; Yiu, ZZ | 1 |
1 review(s) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and thiazoles
| Article | Year |
|---|---|
Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Antagonists; Administration, Oral; Arthritis, Psoriatic; Azetidines; Biological Factors; Biological Therapy; Clinical Trials as Topic; Humans; Isonicotinic Acids; Janus Kinases; Niacinamide; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Lysosphingolipid; rho-Associated Kinases; Sulfonamides; Thalidomide; Thiazoles | 2016 |
3 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and thiazoles
| Article | Year |
|---|---|
Inhibition of cyclooxygenase-2 promotes the stimulatory action of adenosine A₃ receptor agonist on hematopoiesis in sublethally γ-irradiated mice.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Cell Count; Crosses, Genetic; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Erythroid Precursor Cells; Gamma Rays; Granulocyte Colony-Stimulating Factor; Granulocyte Precursor Cells; Hematinics; Hematopoiesis; Hematopoietic Stem Cells; Male; Meloxicam; Mice; Mice, Inbred CBA; Radiation Injuries, Experimental; Thiazines; Thiazoles; Whole-Body Irradiation | 2011 |
Agonist of the adenosine A3 receptor, IB-MECA, and inhibitor of cyclooxygenase-2, meloxicam, given alone or in a combination early after total body irradiation enhance survival of γ-irradiated mice.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Interactions; Gamma Rays; Male; Meloxicam; Mice; Radiation-Protective Agents; Receptor, Adenosine A3; Survival Rate; Thiazines; Thiazoles; Time Factors; Whole-Body Irradiation | 2014 |
Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; HEK293 Cells; Humans; Hyperalgesia; K Cl- Cotransporters; Male; Mice; Pain Threshold; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Sciatica; Signal Transduction; Spinal Nerve Roots; Symporters; Thiazoles; Thioglycolates | 2015 |